Is Cohance Lifesciences Limited FDA approved?

Cohance Lifesciences Limited holds 6 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Cohance Lifesciences Limited's drugs manufactured?

The FDA register lists Ankleshwar; Medchal-Malkajgiri; NTR; Rangareddy; Sangareddy. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging.

What drugs does Cohance Lifesciences Limited make?

74 products are listed under Cohance Lifesciences Limited in the openFDA NDC Directory, most often as powder; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Cohance Lifesciences Limited

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 6
Active NDC listings: 74
Labeller names: 2
Live patents: 0
Countries: 1
Base: India

Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture4Labelling2Finished drug manufacture3Packaging2Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Cohance Lifesciences Limited	API Unit-III, 3102/B, GIDC, Ankleshwar, Gujarat 393002, India (IND)	Active ingredient (API) manufacture	3003650383915838074
COHANCE LIFESCIENCES LIMITED	Plot No. A-19/C, A-23A, & A-23B, Road No. 18, IDA Nacharam, Uppal Mandal, Medchal-Malkajgiri, Telangana 500076, India (IND)	Finished drug manufacture	3008768274677637710
Cohance Lifesciences Limited	API Unit-IV, Plot No. A-21, road No.10, IDA Nacharam, Uppal Mandal,, Medchal-Malkajgiri, Telangana 500076, India (IND)	Active ingredient (API) manufacture	3006493505675623773
COHANCE LIFESCIENCES LIMITED	R.S.No.50/1, Mukteswarapuram Village Jaggaiahpet Mandal, NTR, Andhra Pradesh 521457, India (IND)	Active ingredient (API) manufacture	3005554260650488088
Cohance Lifesciences Limited	Survey No. 99/1, Plot No-9A(1), Mamidipally Village, Balapur Mandal, Samshabad, Rangareddy, Telangana 500108, India (IND)	Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging	3019037664854125972
Cohance Lifesciences Limited	Plot Nos. 262 To 271, IDA Pashamylaram, Sangareddy, Telangana 502307, India (IND)	Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging	1000623515677604288

Catalogue

Drug listings by form and route

74 active NDC listings: 74 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 38, BULK INGREDIENT 36.

Dosage form	NDCs
powder	71
tablet	3

Route	NDCs

Labeller name on the listing	NDCs
cohance lifesciences limited	49
cohance lifesciences limited	25

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	APIXABAN	powder	76072-1017BULK INGREDIENT
-	ARIPIPRAZOLE	powder	76072-1002BULK INGREDIENT
-	ATOMOXETINE HYDROCHLORIDE	powder	76072-1011BULK INGREDIENT
-	Baclofen	tablet	17511-130BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Betahistine Hydrochloride	powder	76072-1001BULK INGREDIENT
-	Bretylium Tosylate	powder	68022-7060BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Buspirone Hydrochloride (BPN)	powder	76072-1020BULK INGREDIENT
-	Calcium Acetate	powder	68022-7025BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Carprofen	powder	68022-7010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Chloroquine phosphate	powder	68022-7057BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Clozapine	powder	76072-1010BULK INGREDIENT
-	Danofloxacin Mesylate	powder	68022-7524BULK INGREDIENT
-	Dapagliflozin Propanediol Monohydrate	powder	76072-1014BULK INGREDIENT
-	Dapsone	powder	76072-1018BULK INGREDIENT
-	Diflunisal	tablet	17511-129BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Dipyridamole	powder	17511-122BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Doxazosin mesylate	powder	17511-113BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Doxofylline	powder	68022-7007BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	ESLICARBAZEPINE ACETATE	powder	76072-1005BULK INGREDIENT
-	Edetate Calcium Disodium dihydrate	powder	68022-7059BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Empagliflozin	powder	76072-1015BULK INGREDIENT
-	Entacapone	powder	17511-109BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Entacapone	powder	68022-7043BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	FLUVOXAMINE MALEATE	powder	76072-1003BULK INGREDIENT
-	Ferric Carboxy Maltose	powder	68022-7070BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Ferric citrate	powder	17511-124BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Fluphenazine Hydrochloride	powder	68022-7063BULK INGREDIENT
-	Flurbiprofen	powder	17511-123BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Fomepizole	powder	17511-101BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Gabapentin	powder	68022-7006BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Glycopyrrolate	powder	68022-7048BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Glycopyrrolate Tosylate	powder	68022-7054BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Hydralazine Hydrochloride	powder	17511-102BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	ITRACONAZOLE	powder	17511-114BULK INGREDIENT
-	Iron Sucrose Complex	powder	68022-7032BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Iron Sucrose Complex	powder	68022-7510BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Isosulfan Blue	powder	68022-7525BULK INGREDIENT
-	L-Carglumic acid	powder	68022-7523BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Lamotrigine	powder	17511-103BULK INGREDIENT
-	Lamotrigine	powder	68022-7036BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Levocetirizine Dihydrochloride	powder	17511-106BULK INGREDIENT
-	Lurasidone Hydrochloride	powder	76072-1007BULK INGREDIENT
-	MEMANTINE HYDROCHLORIDE	powder	76072-1004BULK INGREDIENT
-	Maraviroc	powder	76072-1019BULK INGREDIENT
-	Meclizine Hydrochloride	powder	17511-108BULK INGREDIENT
-	Metaxalone	powder	17511-104BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Methylene Blue	powder	68022-7067BULK INGREDIENT
-	Metyrosine	powder	68022-7056BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Mexiletine Hydrochloride	powder	17511-136BULK INGREDIENT
-	Midazolam	powder	17511-115BULK INGREDIENT
-	Midazolam Hydrochloride	powder	17511-134BULK INGREDIENT
-	Mirabegron	powder	76072-1013BULK INGREDIENT
-	Nitazoxanide	powder	68022-7020BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Nitisinone	powder	68022-7058BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	PIRFENIDONE	powder	76072-1006BULK INGREDIENT
-	Penicillamine	powder	68022-7041BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Posaconazole	powder	17511-133BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Probenecid	powder	68022-7061BULK INGREDIENT
-	Propiomazine maleate	tablet	17511-128BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	QUETIAPINE FUMARATE	powder	76072-1009BULK INGREDIENT
-	Rifapentine	powder	68022-7055BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Rivaroxaban	powder	76072-1008BULK INGREDIENT
-	Sodium Ferric Gluconate Complex	powder	68022-7505BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Sulfasalazine	powder	68022-7068BULK INGREDIENT
-	TICAGRELOR	powder	76072-1016BULK INGREDIENT
-	TK112690	powder	17511-135BULK INGREDIENT
-	TOLCAPONE	powder	17511-119BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Tamsulosin Hydrochloride	powder	17511-118BULK INGREDIENT
-	Thiabendazole	powder	68022-7046BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Thiamine Hydrochloride	powder	68022-7515BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Trientine Hydrochloride	powder	68022-7052BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Verapamil Hydrochloride	powder	17511-132BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Zonisamide	powder	17511-137BULK INGREDIENT
-	Zonisamide	powder	76072-1012BULK INGREDIENT

Neighbours

Registered in the same town

Dr. Reddy's Laboratories LimitedMedchal-Malkajgiri, IND; Sangareddy, IND · 6 sites
Apitoria Pharma Private LimitedSangareddy, IND · 5 sites
Viyash Scientific LimitedMedchal-Malkajgiri, IND; Sangareddy, IND · 3 sites
Arene Life Sciences Private LimitedSangareddy, IND · 3 sites
Aurobindo Pharma LimitedSangareddy, IND · 2 sites
EUGIA Pharma Specialities LimitedMedchal-Malkajgiri, IND; Sangareddy, IND · 2 sites
NATCO PHARMA LIMITEDRangareddy, IND · 2 sites
Honour Lab LimitedSangareddy, IND · 2 sites
Cadila Pharmaceuticals LimitedAnkleshwar, IND · 2 sites
Metrochem API Private LimitedSangareddy, IND · 2 sites
BE BIOSOL PRIVATE LIMITEDMedchal-Malkajgiri, IND · 2 sites
Lupin LimitedAnkleshwar, IND

Compare

Comparable companies in India

Aurobindo Pharma Limited6 sites · 1,453 NDC
SOLARA ACTIVE PHARMA SCIENCES LIMITED6 sites · 40 NDC
Intas Pharmaceuticals Limited6 sites · 12 NDC
Alembic Pharmaceuticals Limited7 sites · 998 NDC
Macleods Pharmaceuticals Limited5 sites · 390 NDC
CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
Unichem Laboratories Limited, India5 sites · 272 NDC
Strides Pharma Science Limited5 sites · 230 NDC
Par Health USA, LLC5 sites · 211 NDC
Torrent Pharma, Inc.5 sites · 184 NDC

Enquiry

Common questions

Is Cohance Lifesciences Limited FDA approved?: Cohance Lifesciences Limited holds 6 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Cohance Lifesciences Limited's drugs manufactured?: The FDA register lists Ankleshwar; Medchal-Malkajgiri; NTR; Rangareddy; Sangareddy. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging.
What drugs does Cohance Lifesciences Limited make?: 74 products are listed under Cohance Lifesciences Limited in the openFDA NDC Directory, most often as powder; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.